- $946.71m
- $573.59m
U.S. STOCKS ON THE MOVE-Energy stocks, Netflix, Ross Stores
ArriVent BioPharma drops after $75 mln equity raise
Brief: Arrivent Announces Pricing Of $75 Million Public Offering Of Common Stock And Pre-Funded Warrants
ArriVent BioPharma falls on planned $75 mln stock sale
Brief: Arrivent Proposes $75 Million Public Offering of Common Stock and Pre-Funded Warrants
Brief: Arrivent Announces Positive Interim Firmonertinib Monotherapy Data From Global Phase 1B Study
Arrivent Biopharma Inc expected to post a loss of 66 cents a share - Earnings Preview
HK-listed Lepu jumps most in 5 weeks on exclusive deal with ArriVent BioPharma
Brief: Lepu Biopharma Says Exclusive License Agreement For Novel Adc Mrg007
Brief: Arrivent Biopharma Enters Exclusive License With Lepu Biopharma For Mrg007, An Antibody Drug Conjugate
Brief: ArriVent Announces Multi-Target ADC Collaboration With Alphamab
Brief: Arrivent Appoints John Hohneker To Its Board Of Directors
U.S. RESEARCH ROUNDUP-Arrivent Biopharma, Ferguson, Target
U.S. RESEARCH ROUNDUP-Ball, Couchbase, Holley
Brief: Arrivent Announces Pricing Of Upsized Initial Public Offering